What is MaxCyte's other income (expense)?

MaxCyte (MXCT) reported other income (expense) of $1.44M in Q1 2026.

How has MaxCyte's other income (expense) changed year-over-year?

MaxCyte's other income (expense) decreased by 29.4% year-over-year, from $2.03M to $1.44M.

What is the long-term trend for MaxCyte's other income (expense)?

Over 4 years (2021 to 2025), MaxCyte's other income (expense) has grown at a 65.2% compound annual growth rate (CAGR), from -$974.6K to $7.27M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

MaxCyte MXCT Other Income (Expense)

Other Income (Expense) at other companies

Bio-Rad LaboratoriesBIO

$24.2M-34.9%

Ginkgo BioworksDNA

-$4.77M-112%

Immix Biopharma, Inc.IMMX

$717.17K+377%

Rapid Micro BiosystemsRPID

-$415K-202%

RepligenRGEN

-$14.17M-1,138%

TEC

Bio-TechneTECH

-$4.27M-884%

Segments

By segment

See full

Cell Engineering Technology$1.44M-29.4%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's other income (expense)?: MaxCyte (MXCT) reported other income (expense) of $1.44M in Q1 2026.
How has MaxCyte's other income (expense) changed year-over-year?: MaxCyte's other income (expense) decreased by 29.4% year-over-year, from $2.03M to $1.44M.
What is the long-term trend for MaxCyte's other income (expense)?: Over 4 years (2021 to 2025), MaxCyte's other income (expense) has grown at a 65.2% compound annual growth rate (CAGR), from -$974.6K to $7.27M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.